VJHemOnc shared a post on X:
“It was great to catch up with Mazyar Shadman at ASCO24 to find out if BTK inhibitors are a suitable treatment option for patients with CLL and cardiovascular comorbidities.
Click here to watch.”
Source: VJHemOnc/X
VJHemOnc shared a post on X:
“It was great to catch up with Mazyar Shadman at ASCO24 to find out if BTK inhibitors are a suitable treatment option for patients with CLL and cardiovascular comorbidities.
Click here to watch.”
Source: VJHemOnc/X